PTAB Evidence Rules Clarified, Affirming Genzyme Loss
The Federal Circuit affirmed a decision that found parts of two patents covering methods of treating a muscle disease were invalid, issuing a ruling Tuesday that clarifies what evidence the Patent...To view the full article, register now.
Already a subscriber? Click here to view full article